These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 20089489

  • 1. Randomized, double-blind, controlled study of losartan in children with proteinuria.
    Webb NJ, Lam C, Loeys T, Shahinfar S, Strehlau J, Wells TG, Santoro E, Manas D, Gleim GW.
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):417-24. PubMed ID: 20089489
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial.
    Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C.
    Nephrol Dial Transplant; 2011 Aug; 26(8):2521-6. PubMed ID: 21285125
    [Abstract] [Full Text] [Related]

  • 3. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):189-95. PubMed ID: 22462558
    [Abstract] [Full Text] [Related]

  • 5. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May 01; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 6. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
    Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marín R, Campistol JM.
    Nephrol Dial Transplant; 2003 Sep 01; 18(9):1806-13. PubMed ID: 12937228
    [Abstract] [Full Text] [Related]

  • 7. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP, Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Virolainen J, Kontula K.
    Am J Hypertens; 2007 Mar 01; 20(3):311-8. PubMed ID: 17324745
    [Abstract] [Full Text] [Related]

  • 8. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct 01; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 9. The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.
    Phillips RA, Kloner RA, Grimm RH, Weinberger M.
    J Clin Hypertens (Greenwich); 2003 Oct 01; 5(1):17-23. PubMed ID: 12556649
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of a fixed-dose combination of metoprolol extended release/amlodipine in patients with mild-to-moderate hypertension: a randomized, parallel-group, multicentre comparison with losartan plus amlodipine.
    Pareek A, Chandurkar NB, Sharma R, Tiwari D, Gupta BS.
    Clin Drug Investig; 2010 Oct 01; 30(2):123-31. PubMed ID: 20067330
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
    Coto E, Marín R, Alvarez V, Praga M, Fernández Andrade C, Arias M, Poveda R, Vallés M, Galcerán JM, Luño J, Rivera F, Campistol JM.
    Nefrologia; 2005 Oct 01; 25(4):381-6. PubMed ID: 16231503
    [Abstract] [Full Text] [Related]

  • 12. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE.
    J Hum Hypertens; 2006 Nov 01; 20(11):860-6. PubMed ID: 16988754
    [Abstract] [Full Text] [Related]

  • 13. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH, Park SJ, Kim EJ, Kim SJ, Cho HJ, Song JM, Shin J, Park JJ, Shin JH, Han KR, Choi DJ.
    Trials; 2018 Jun 20; 19(1):324. PubMed ID: 29925421
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM, Youn JC, Chae SC, Park CG, Yang JY, Kim MH, Hong TJ, Kim CH, Kim JJ, Shin DG, Jeong JW, Yoon JH, Park SH, Kwon J, Cho SY.
    Clin Ther; 2011 Dec 20; 33(12):1953-63. PubMed ID: 22136978
    [Abstract] [Full Text] [Related]

  • 15. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr 20; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 16. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW, Lacourcière Y, Barnes CC.
    CMAJ; 1998 Sep 08; 159(5):469-76. PubMed ID: 9757170
    [Abstract] [Full Text] [Related]

  • 17. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.
    Holdaas H, Hartmann A, Berg KJ, Lund K, Fauchald P.
    Nephrol Dial Transplant; 1998 Dec 08; 13(12):3096-102. PubMed ID: 9870472
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M, Brommer P, Haag U, Miele C.
    Clin Drug Investig; 2009 Dec 08; 29(1):11-25. PubMed ID: 19067471
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH, Jeon HK, Cha TJ, Hong TJ, Kim SH, Lee NH, Yoon JH, Yoon N, Hwang KK, Jo SH, Youn HJ.
    Drug Des Devel Ther; 2016 Dec 08; 10():3817-3826. PubMed ID: 27920497
    [Abstract] [Full Text] [Related]

  • 20. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC, Liu CP, Chiang HT, Lin SL.
    Heart Vessels; 2004 Jan 08; 19(1):13-8. PubMed ID: 14685749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.